1. Mechanisms of Acute Myocardial Infarction --;2. New Generation Thrombolytic Agents --;3. Antiplatelet Agents --;4. Thrombin Inhibitors --;5. The Thrombolysis in Myocardial Infarction (TIMI) Trials --;6. The Clinical Trials of the European Cooperative Study for Recombinant Tissue-Type Plasminogen Activator (rt-PA) --;7. The International Studies of Infarct Survival (ISIS) --;8. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Trials --;9. Trial of Prehospital Thrombolysis for Acute Myocardial Infarction: Is Sooner Necessarily Better? --;10. The Late Assessment of Thrombolytic Efficacy (LATE) Trial: Impact and Implications --;11. The Global Utilization of t-PA and Streptokinase for Occluded Coronary Arteries (GUSTO-I) Trial --;12. The Management of Heart Failure in the Age of Reperfusion --;13. Thrombolytic Therapy in Elderly Patients --;14. Thrombolytic Retreatment for Coronary Arterial Reocclusion --;15. Radionuclide Imaging Techniques in the Thrombolytic Era --;16. Biochemical Markers of Coronary Recanalization after Fibrinolytic Therapy --;17. Monitoring Anticoagulant Therapy in the Setting of Thrombolytic Therapy --;18. Acute Coronary Syndromes: Focus on Unstable Angina --;19. Future of Coronary Thrombolysis.
یادداشتهای مربوط به خلاصه یا چکیده
متن يادداشت
Thrombolytic therapy has revolutionized the treatment of myocardial infarction, saving lives to a greater extent than any treatment developed to date. The emergence of information vital for patient care has appeared at an extraordinary pace, with hundreds of articles being published yearly.
موضوع (اسم عام یاعبارت اسمی عام)
موضوع مستند نشده
Cardiology.
موضوع مستند نشده
Hematology.
موضوع مستند نشده
Medicine.
رده بندی کنگره
شماره رده
RC685
.
C6
نشانه اثر
E358
1994
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )